<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We aimed to perform a preliminary study of the association between induced pluripotent stem cell (iPS)-related genes and biological behavior of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells, and the potential for developing anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs targeting these genes </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We used real-time reverse transcriptase polymerase chain reaction (RT-PCR) to evaluate the transcript levels of iPS-related genes NANOG, OCT4, SOX2, C-MYC and KLF4 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>)-enriched <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> spheres </plain></SENT>
<SENT sid="2" pm="."><plain>NANOG was knockdowned in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell line SW620 by lentiviral transduction </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="53233">3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</z:chebi> (<z:chebi fb="0" ids="53233">MTT</z:chebi>) assays, plate colony formation, and a mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> were used to evaluate alterations in biological behavior in NANOG-knockdown SW620 cells </plain></SENT>
<SENT sid="4" pm="."><plain>Also, mock-knockdown and NANOG-knockdown cells were treated with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU) and survival rate was measured by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay to evaluate drug sensitivity </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A significant difference in the transcript levels of iPS-related genes between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> spheres and their parental bulky cells was observed </plain></SENT>
<SENT sid="6" pm="."><plain>NANOG knockdown suppressed proliferation, colony formation, and in vivo tumorigenicity but increased the sensitivity to 5-FU of SW620 cells </plain></SENT>
<SENT sid="7" pm="."><plain>5-FU treatment greatly inhibited the expression of the major stemness-associated genes NANOG, OCT4, and SOX2 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These results collectively suggest an overlap between iPS-related genes and <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Quenching a certain gene NANOG may truncate the <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
</text></document>